Curcumin for inflammation in dialysis patients
Treatments studied
Part of Kidney & urinary clinical trials.
This trial studies whether curcumin (the active ingredient in turmeric) can help reduce inflammation in people on dialysis. You may continue your regular kidney treatment while taking curcumin, and the study will check your blood for changes in inflammation markers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and are on dialysis or hemodialysis (kidney treatment).
- You have been having dialysis for at least 3 months and are otherwise stable.
- You do not have serious health issues like cancer, severe heart failure, active infections, or autoimmune diseases.
- You are not pregnant, not a smoker, and have no severe liver disease or known allergies to the study product.
- You agree to continue your prescribed medications and any usual supplements or turmeric use during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a therapy that absorbs inflammatory substances from the blood during dialysis. It may help people on dialysis who have ongoing inflammation, shown by high IL-6 or CRP levels.
This study tests whether taking a special mix of friendly bacteria and prebiotics (called synbiotics) can help improve gut health in people on hemodialysis. It may reduce inflammation and other complications related to kidney disease.
This study tests whether taking probiotics or synbiotics (supplements that support gut health) can improve nutritional status in people on regular hemodialysis. It may help you feel better and stay stronger if you are on dialysis.
This study tests whether taking a very high dose of vitamin D3 can reduce moderate to severe chronic pain in people on hemodialysis. It may help by improving vitamin D-related pathways that could affect pain, but you must also meet specific health and testing requirements.
This study tests whether adding a special blood-cleaning treatment called hemoperfusion to regular dialysis can improve health outcomes for people with kidney failure. It aims to see if this extra treatment helps patients feel better and live longer.
This trial tests whether a daily supplement of synbiotics—a mix of beneficial bacteria and fiber—can help reduce inflammation in people with chronic kidney disease who are not yet on dialysis. Taking this supplement might improve your kidney health and overall well-being.
Hear when a new Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.